304 related articles for article (PubMed ID: 12875523)
1. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
2. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
3. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline: its potential for treatment of brucellosis.
Dizbay M; Kilic S; Hizel K; Arman D
Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
10. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
15. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
17. [In vitro sensitivity to five antibiotics of clinical isolated Brucella spp].
Efron A; Lopardo H; Lucero NE
Rev Argent Microbiol; 1999; 31 Suppl 1():56-7. PubMed ID: 10509415
[No Abstract] [Full Text] [Related]
18. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
[TBL] [Abstract][Full Text] [Related]
19. Identification of Brucella species isolated from proven brucellosis patients in Izmir, Turkey.
Köse S; Kiliç S; Ozbel Y
J Basic Microbiol; 2005; 45(4):323-7. PubMed ID: 16028204
[TBL] [Abstract][Full Text] [Related]
20. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
Orhan G; Bayram A; Zer Y; Balci I
J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]